Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
NCT ID: NCT06522334
Last Updated: 2025-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2024-02-28
2034-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There are no additional interventions regarding this registry.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING
NCT02645968
Database for Interstitial Lung Disease
NCT04707781
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
NCT02951416
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327
Epidemiology of Interstitial Lung Disease
NCT00005290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig Boltzmann Institute for Lung Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robab Breyer-Kohansal
Head of Department for Internal Medicine and Pneumology Clinic Hietzing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik Hietzing
Vienna, , Austria
Klinik Penzing
Vienna, , Austria
Ludwig Boltzmann Institut for Lung Health
Vienna, , Austria
Klinik Ottakring
Vienna, , Austria
Klinik Floridsdorf
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILD Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.